MedTrace Logo

De-implementing Inhaled Steroids to Improve Care and Safety in COPD

NCT02896257 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 181

Last updated 2023-07-27

Study results available
· View outcomes & findings →

Summary

This Quality Enhancement Research Initiative (QuERI) project is designed to determine efficacy and acceptance of an intervention method to provide primary care providers with patient-tailored electronic consults and corresponding unsigned orders for de-implementation of inhaled corticosteroids (ICS) for patients with COPD when ICS are not indicated by guidelines.

Conditions

  • Treatment of Chronic Obstructive Pulmonary Disease

Interventions

OTHER

Guideline treatment recommendations

Patient-tailored E-consult, orders and rationale to discontinue inhaled corticosteroids and discontinue or receive other COPD related care.

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • David H. Au, MD MS · VA Puget Sound Health Care System Seattle Division, Seattle, WA

  • Christian D. Helfrich, PhD MPH BA · VA Puget Sound Health Care System Seattle Division, Seattle, WA

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-06
Primary Completion
2019-07-29
Completion
2021-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02896257 on ClinicalTrials.gov